We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
Cap. Flow
+$518M
Cap. Flow %
0.87%
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$68M
2
TFC icon
Truist Financial
TFC
+$55.9M
3
NOW icon
ServiceNow
NOW
+$33.3M
4
UBER icon
Uber
UBER
+$21.4M
5
LVS icon
Las Vegas Sands
LVS
+$15.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$119M
2
STI
SunTrust Banks, Inc.
STI
+$55.9M
3
AAPL icon
Apple
AAPL
+$48.3M
4
TIP icon
iShares TIPS Bond ETF
TIP
+$22M
5
VIAB
Viacom Inc. Class B
VIAB
+$16.4M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Financials 15.53%
3 Healthcare 13.38%
4 Consumer Discretionary 10.07%
5 Industrials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OSG
2701
DELISTED
Overseas Shipholding Group Inc.
OSG
$230K ﹤0.01%
99,802
-140
-0.1% -$260
CLPR
2702
Clipper Realty
CLPR
$44.8M
$229K ﹤0.01%
21,559
+727
+3% +$6.94K
PVLA
2703
Palvella Therapeutics
PVLA
$2.18B
$229K ﹤0.01%
790
+4
+0.5% +$1.11K
ESQ icon
2704
Esquire Financial Holdings
ESQ
$1.13B
$228K ﹤0.01%
8,756
-30
-0.3% -$733
FET icon
2705
Forum Energy Technologies
FET
$836M
$228K ﹤0.01%
6,797
-2,229
-25% -$60.4K
DSKE
2706
DELISTED
Daseke, Inc. Common Stock
DSKE
$228K ﹤0.01%
72,121
+930
+1% +$2.72K
CURO
2707
DELISTED
CURO Group Holdings Corp.
CURO
$228K ﹤0.01%
18,692
+102
+0.5% +$1.36K
RJET
2708
Republic Airways Holdings
RJET
$1.03B
$226K ﹤0.01%
1,685
+18
+1% +$2.08K
DGICA icon
2709
Donegal Group Class A
DGICA
$721M
$225K ﹤0.01%
15,207
+179
+1% +$2.62K
STOK icon
2710
Stoke Therapeutics
STOK
$1.97B
$225K ﹤0.01%
+7,939
New +$200K
PMBC
2711
DELISTED
Pacific Mercantile Bancorp
PMBC
$225K ﹤0.01%
27,761
-12
-0% -$88
GNK icon
2712
Genco Shipping & Trading
GNK
$1.13B
$224K ﹤0.01%
21,089
+150
+0.7% +$1.54K
ELOX
2713
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$224K ﹤0.01%
762
+7
+0.9% +$1.41K
ULH icon
2714
Universal Logistics Holdings
ULH
$513M
$223K ﹤0.01%
11,755
-99
-0.8% -$2.06K
NESR
2715
National Energy Services Reunited Corp
NESR
$2.9B
$222K ﹤0.01%
24,328
+500
+2% +$3.87K
JNCE
2716
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$221K ﹤0.01%
25,305
+276
+1% +$1.49K
OCUL icon
2717
Ocular Therapeutix
OCUL
$1.89B
$220K ﹤0.01%
55,710
+4,864
+10% +$16.9K
XERS icon
2718
Xeris Biopharma Holdings
XERS
$1.41B
$220K ﹤0.01%
31,184
+349
+1% +$2.88K
PZN
2719
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$220K ﹤0.01%
25,471
-15
-0.1% -$129
PHAT icon
2720
Phathom Pharmaceuticals
PHAT
$684M
$218K ﹤0.01%
+6,986
New +$176K
ASPS icon
2721
Altisource Portfolio Solutions
ASPS
$60M
$216K ﹤0.01%
1,394
-30
-2% -$4.6K
TNAV
2722
DELISTED
Telenav Inc.
TNAV
$216K ﹤0.01%
44,513
+175
+0.4% +$852
SIC
2723
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
$215K ﹤0.01%
23,919
+113
+0.5% +$1.2K
REPL icon
2724
Replimune Group
REPL
$1B
$214K ﹤0.01%
14,898
+365
+3% +$5.26K
REV
2725
DELISTED
Revlon, Inc.
REV
$214K ﹤0.01%
9,983
+17
+0.2% +$410
107 108
109
110 111

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
  • RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
  • RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
  • RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
  • RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
  • RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
  • RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.

Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.